Inventiva PT Lowered to 13.00
IVA Stock | USD 2.65 0.03 1.12% |
About 61% of Inventiva's investor base is looking to short. The analysis of the overall investor sentiment regarding Inventiva Sa suggests that many traders are alarmed. The current market sentiment, together with Inventiva's historical and current headlines, can help investors time the market. In addition, many technical investors use Inventiva Sa stock news signals to limit their universe of possible portfolio assets.
Inventiva |
Inventiva had its target price trimmed by HC Wainwright from 14.00 to 13.00 in a research note published on Tuesday morning, Benzinga reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for Inventivas FY2026 earnings at EPS, FY2027 earnings at EPS and
Read at thelincolnianonline.com
Inventiva Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Inventiva can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Inventiva Fundamental Analysis
We analyze Inventiva's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inventiva using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inventiva based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Inventiva is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Inventiva Sa Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Inventiva stock to make a market-neutral strategy. Peer analysis of Inventiva could also be used in its relative valuation, which is a method of valuing Inventiva by comparing valuation metrics with similar companies.
Peers
Inventiva Related Equities
GLUE | Monte Rosa | 13.72 | ||||
VIGL | Vigil Neuroscience | 7.39 | ||||
CMPX | Compass Therapeutics | 4.49 | ||||
VRCA | Verrica Pharmaceuticals | 3.23 | ||||
CGEM | Cullinan Oncology | 2.75 | ||||
IPHA | Innate Pharma | 2.67 | ||||
EWTX | Edgewise Therapeutics | 2.48 | ||||
VTYX | Ventyx Biosciences | 1.13 | ||||
RZLT | Rezolute | 1.00 | ||||
ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
PCVX | Vaxcyte | 0.38 | ||||
IMCR | Immunocore Holdings | 0.27 | ||||
ACLX | Arcellx | 1.12 | ||||
ELYM | Eliem Therapeutics | 1.30 | ||||
INBX | Inhibrx | 2.37 | ||||
JANX | Janux Therapeutics | 2.54 | ||||
MLYS | Mineralys Therapeutics, | 2.59 | ||||
NAMS | NewAmsterdam Pharma | 4.57 | ||||
HCWB | HCW Biologics | 6.00 |
Complementary Tools for Inventiva Stock analysis
When running Inventiva's price analysis, check to measure Inventiva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inventiva is operating at the current time. Most of Inventiva's value examination focuses on studying past and present price action to predict the probability of Inventiva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inventiva's price. Additionally, you may evaluate how the addition of Inventiva to your portfolios can decrease your overall portfolio volatility.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |